BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 19517191)

  • 21. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma.
    Chen PY; Vicini FA; Benitez P; Kestin LL; Wallace M; Mitchell C; Pettinga J; Martinez AA
    Cancer; 2006 Mar; 106(5):991-9. PubMed ID: 16421922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy.
    Gómez-Iturriaga A; Pina L; Cambeiro M; Martínez-Regueira F; Aramendía JM; Fernández-Hidalgo O; Martínez-Monge R
    Brachytherapy; 2008; 7(4):310-5. PubMed ID: 18778971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study.
    Belkacémi Y; Chauvet MP; Giard S; Villette S; Lacornerie T; Bonodeau F; Baranzelli MC; Bonneterre J; Lartigau E
    Radiother Oncol; 2009 Jan; 90(1):23-9. PubMed ID: 18692927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.
    Niehoff P; Polgár C; Ostertag H; Major T; Sulyok Z; Kimmig B; Kovács G
    Radiother Oncol; 2006 Jun; 79(3):316-20. PubMed ID: 16780977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
    Niehoff P; Ballardini B; Polgár C; Major T; Hammer J; Richetti A; Kovács G
    Breast; 2006 Jun; 15(3):319-25. PubMed ID: 16765284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of MammoSite brachytherapy: advantages, disadvantages and clinical outcomes.
    Bensaleh S; Bezak E; Borg M
    Acta Oncol; 2009; 48(4):487-94. PubMed ID: 19031175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary failure in patients treated with MammoSite accelerated partial breast irradiation.
    Aburabia M; Roses RE; Kuerer HM; Fine R; Beitsch PD; Goyal S; Haffty B; Lyden M; Vicini FA
    Ann Surg Oncol; 2011 Nov; 18(12):3415-21. PubMed ID: 21537870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of Chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial.
    Haffty BG; Vicini FA; Beitsch P; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H; Whitacre E; Whitworth P; Fine R; Keisch M
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1441-8. PubMed ID: 18692330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.
    Haley M; Beriwal S; Heron DE; Kim H; Falk J; Johnson R; Mogus R
    Brachytherapy; 2009; 8(1):9-13. PubMed ID: 18955020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial.
    Polgár C; Fodor J; Major T; Németh G; Lövey K; Orosz Z; Sulyok Z; Takácsi-Nagy Z; Kásler M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):694-702. PubMed ID: 17531400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
    Richards GM; Berson AM; Rescigno J; Sanghavi S; Siegel B; Axelrod D; Bernik S; Scarpinato V; Mills C
    Ann Surg Oncol; 2004 Aug; 11(8):739-46. PubMed ID: 15249336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated partial-breast irradiation with interstitial implants: the clinical relevance of the calculation of skin doses.
    Ott OJ; Lotter M; Sauer R; Strnad V
    Strahlenther Onkol; 2007 Aug; 183(8):426-31. PubMed ID: 17680222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary result of accelerated partial breast irradiation after breast-conserving surgery.
    Yoshida K; Nose T; Masuda N; Yamazaki H; Kotsuma T; Yoshida M; Yamamura J; Masuda H; Shin E; Nakaba H; Komoike Y; Tokuda Y; Takeda M; Kuriyama K
    Breast Cancer; 2009; 16(2):105-12. PubMed ID: 18807124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data.
    Wilkinson JB; Beitsch PD; Shah C; Arthur D; Haffty BG; Wazer DE; Keisch M; Shaitelman SF; Lyden M; Chen PY; Vicini FA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1179-85. PubMed ID: 23182700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation.
    Vicini F; Beitsch P; Quiet C; Gittleman M; Zannis V; Fine R; Whitworth P; Kuerer H; Haffty B; Keisch M; Lyden M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):808-17. PubMed ID: 20472364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MammoSite breast brachytherapy applicator: a review of technique and outcomes.
    Dickler A; Kirk MC; Chu J; Nguyen C
    Brachytherapy; 2005; 4(2):130-6. PubMed ID: 15893266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
    Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.